*By clicking the Submit button, I consent to being contacted by Altman-Nussbaum-Shunnarah Personal Injury Attorneys at the number I provided. I also consent to receiving advertisements and telemarketing messages by text message or pre-recorded call, either of which may be dialed by an autodialer. I acknowledge that my consent is not required for purchase, that standard message and data rates apply, and that clicking Submit constitutes my electronic signature for my consent to being contacted and my agreement to the Terms and Conditions.
Altman-Nussbaum-Shunnarah Trial Attorneyss are standing by to help you no matter where you live. Serving all 50 states, we’ve recovered over $500mil for our clients nationwide. After reviewing the results from a safety clinical trial, The FDA has concluded there is an increased risk of death and heart problems when taking Uloric (febuxostat) to treat gout compared to another competitor, allopurinol. Uloric was FDA-approved in 2009 to lower levels of uric acid buildup in the blood, which can lead to gout. As of 2019, Uloric has a Boxed Warning, the most significant warning for complications administered by the FDA.
Patients with a history of heart problems or stroke are at an increased risk taking Uloric.
Altman-Nussbaum-Shunnarah Trial Attorneys is known nationwide for providing outstanding legal advice and excellent representation. We have recovered over $1 billion in lawsuits involving 18 wheeler trucking litigation, wrongful death litigation, commercial vehicle litigation, motorcycle litigation, catastrophic litigation, and mass torts involving medical devices and bad drug litigation. Our prowess in the legal arena comes from our combined years of trial and complex litigation experience.
We founded our practice on the belief that the 7th amendment and the civil jury system is the best means to provide compensation to injured parties and deter wrongdoers from injuring others in the future.
Tell us your story
"*" indicates required fields